Last $2.50 USD
Change Today -0.05 / -1.96%
Volume 185.7K
ANTH On Other Exchanges
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

anthera pharmaceuticals inc (ANTH) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/13/14 - $3.79
52 Week Low
12/23/14 - $1.46
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

anthera pharmaceuticals inc (ANTH) Related Bloomberg News

View More Bloomberg News

anthera pharmaceuticals inc (ANTH) Related Businessweek News

No Related Businessweek News Found

anthera pharmaceuticals inc (ANTH) Details

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing products to treat diseases associated with inflammation and autoimmune diseases. It is developing blisibimod, a Phase III product candidate that targets elevated levels of B-cell activating factor associated with various B-cell mediated autoimmune diseases, including systemic lupus erythematosus, IgA nephropathy, lupus nephritis, multiple myeloma, vasculitis, idiopathic thrombocytopenia purpura, and others. The company was founded in 2004 and is headquartered in Hayward, California.

25 Employees
Last Reported Date: 03/28/14
Founded in 2004

anthera pharmaceuticals inc (ANTH) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $577.3K
Senior Vice President of Finance & Administra...
Total Annual Compensation: $224.6K
Chief Medical Officer and Senior Vice Preside...
Total Annual Compensation: $350.0K
Chief Technology Officer and Senior Vice Pres...
Total Annual Compensation: $340.0K
Compensation as of Fiscal Year 2013.

anthera pharmaceuticals inc (ANTH) Key Developments

Anthera Pharmaceuticals, Inc. Presents at The Trout Group 's Annual 1x1 Management Access Event, Jan-12-2015

Anthera Pharmaceuticals, Inc. Presents at The Trout Group 's Annual 1x1 Management Access Event, Jan-12-2015 . Venue: The Handlery Hotel, 351 Geary Street, Union Square, San Francisco, California, United States.

Anthera Pharmaceuticals Announces Appointment of Klara A. Dickinson as Senior Vice President, Chief Regulatory Officer

Anthera Pharmaceuticals, Inc. announced the appointment of Klara A. Dickinson as Senior Vice President, Chief Regulatory Officer. Ms. Dickinson served as Senior Vice President of Regulatory Affairs and Compliance at Hyperion Therapeutics Inc. from October 2007 to July 2014.

Anthera Pharmaceuticals, Inc. Terminates its Loan and Security Agreement with Square 1 Bank

On December 24, 2014, Anthera Pharmaceuticals, Inc. terminated its Loan and Security Agreement entered into on April 3, 2013 with Square 1 Bank. The square 1 loan agreement as in effect at the time of termination had a maturity date of April 3, 2017. The company had borrowed $10 million under the square 1 loan agreement, which bore interest at an annual rate equal to 1%. Interest was payable in cash on a monthly basis and the company may prepay the principal in whole or in part from time to time without penalty or premium. The outstanding principal and accrued interest at the time of repayment was $1.6 million and was repaid in full on December 24, 2014 using the cash in the cash security account. The square 1 loan agreement contained customary representations and warranties and certain affirmative and negative covenants including, among other things, maintenance of a balance in the cash security account of not less than the lesser of $10.0 million and the aggregate amount all debt, principal, interest and other amounts owed to square 1 Bank in the cash security account and restrictions on mergers.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ANTH:US $2.50 USD -0.05

ANTH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ANTH.
View Industry Companies

Industry Analysis


Industry Average

Valuation ANTH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 13.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTHERA PHARMACEUTICALS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at